Pzena Investment Management LLC Sells 25,824 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Pzena Investment Management LLC trimmed its position in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 3.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 761,615 shares of the company's stock after selling 25,824 shares during the quarter. Pzena Investment Management LLC owned 3.98% of USANA Health Sciences worth $40,823,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Quest Partners LLC bought a new position in shares of USANA Health Sciences during the fourth quarter worth $66,000. CWM LLC raised its holdings in shares of USANA Health Sciences by 49.6% during the fourth quarter. CWM LLC now owns 1,267 shares of the company's stock worth $68,000 after acquiring an additional 420 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of USANA Health Sciences by 60.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company's stock worth $198,000 after acquiring an additional 1,274 shares during the period. Trexquant Investment LP acquired a new stake in shares of USANA Health Sciences during the fourth quarter worth $266,000. Finally, Teacher Retirement System of Texas acquired a new stake in shares of USANA Health Sciences during the third quarter worth $297,000. 54.25% of the stock is owned by institutional investors.

USANA Health Sciences Stock Down 1.5 %

Shares of NYSE:USNA traded down $0.74 during midday trading on Thursday, reaching $47.82. 54,526 shares of the company were exchanged, compared to its average volume of 79,646. USANA Health Sciences, Inc. has a fifty-two week low of $41.45 and a fifty-two week high of $69.60. The stock has a fifty day simple moving average of $46.31 and a two-hundred day simple moving average of $48.09. The firm has a market cap of $910.97 million, a PE ratio of 14.90, a P/E/G ratio of 1.49 and a beta of 0.94.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its quarterly earnings results on Tuesday, April 30th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.17. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. The firm had revenue of $227.80 million for the quarter, compared to analyst estimates of $223.27 million. As a group, analysts forecast that USANA Health Sciences, Inc. will post 2.78 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, DA Davidson dropped their price objective on shares of USANA Health Sciences from $48.00 to $46.00 and set a "neutral" rating on the stock in a report on Tuesday, May 7th.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, insider Daniel A. Macuga sold 3,791 shares of USANA Health Sciences stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total value of $178,707.74. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, insider Daniel A. Macuga sold 3,791 shares of the firm's stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total value of $178,707.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider David Mulham Mulham sold 4,311 shares of the firm's stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $47.76, for a total transaction of $205,893.36. Following the completion of the sale, the insider now owns 7,825 shares of the company's stock, valued at $373,722. The disclosure for this sale can be found here. In the last three months, insiders have sold 37,000 shares of company stock worth $1,766,074. Insiders own 0.33% of the company's stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.